Pharmacological studies on new potent central depressants, 8-chloro-6-phenyl-4H-s-triazolo [4,3a][1,4] benzodiazepine (D-40tA) and its 1-methyl analogue (D-65MT). 1971

R Nakajima, and Y Take, and R Moriya, and Y Saji, and T Yui, and Y Nagawa

UI MeSH Term Description Entries
D007274 Injections, Intraperitoneal Forceful administration into the peritoneal cavity of liquid medication, nutrient, or other fluid through a hollow needle piercing the abdominal wall. Intraperitoneal Injections,Injection, Intraperitoneal,Intraperitoneal Injection
D007928 Lethal Dose 50 The dose amount of poisonous or toxic substance or dose of ionizing radiation required to kill 50% of the tested population. LD50,Dose 50, Lethal
D008297 Male Males
D008635 Mescaline Hallucinogenic alkaloid isolated from the flowering heads (peyote) of Lophophora (formerly Anhalonium) williamsii, a Mexican cactus used in Indian religious rites and as an experimental psychotomimetic. Among its cellular effects are agonist actions at some types of serotonin receptors. It has no accepted therapeutic uses although it is legal for religious use by members of the Native American Church. Mezcalin,Peyote,Trimethoxyphenethylamine,3,4,5-Trimethoxyphenethylamine
D008694 Methamphetamine A central nervous system stimulant and sympathomimetic with actions and uses similar to DEXTROAMPHETAMINE. The smokable form is a drug of abuse and is referred to as crank, crystal, crystal meth, ice, and speed. Deoxyephedrine,Desoxyephedrine,Desoxyn,Madrine,Metamfetamine,Methamphetamine Hydrochloride,Methylamphetamine,N-Methylamphetamine,Hydrochloride, Methamphetamine,N Methylamphetamine
D009020 Morphine The principal alkaloid in opium and the prototype opiate analgesic and narcotic. Morphine has widespread effects in the central nervous system and on smooth muscle. Morphine Sulfate,Duramorph,MS Contin,Morphia,Morphine Chloride,Morphine Sulfate (2:1), Anhydrous,Morphine Sulfate (2:1), Pentahydrate,Oramorph SR,SDZ 202-250,SDZ202-250,Chloride, Morphine,Contin, MS,SDZ 202 250,SDZ 202250,SDZ202 250,SDZ202250,Sulfate, Morphine
D009043 Motor Activity Body movements of a human or an animal as a behavioral phenomenon. Activities, Motor,Activity, Motor,Motor Activities
D009125 Muscle Relaxants, Central A heterogeneous group of drugs used to produce muscle relaxation, excepting the neuromuscular blocking agents. They have their primary clinical and therapeutic uses in the treatment of muscle spasm and immobility associated with strains, sprains, and injuries of the back and, to a lesser degree, injuries to the neck. They have been used also for the treatment of a variety of clinical conditions that have in common only the presence of skeletal muscle hyperactivity, for example, the muscle spasms that can occur in MULTIPLE SCLEROSIS. (From Smith and Reynard, Textbook of Pharmacology, 1991, p358) Centrally Acting Muscle Relaxants,Central Muscle Relaxants,Relaxants, Central Muscle
D012110 Reserpine An alkaloid found in the roots of Rauwolfia serpentina and R. vomitoria. Reserpine inhibits the uptake of norepinephrine into storage vesicles resulting in depletion of catecholamines and serotonin from central and peripheral axon terminals. It has been used as an antihypertensive and an antipsychotic as well as a research tool, but its adverse effects limit its clinical use. Raunervil,Raupasil,Rausedil,Rausedyl,Serpasil,Serpivite,V-Serp,V Serp
D002415 Cats The domestic cat, Felis catus, of the carnivore family FELIDAE, comprising over 30 different breeds. The domestic cat is descended primarily from the wild cat of Africa and extreme southwestern Asia. Though probably present in towns in Palestine as long ago as 7000 years, actual domestication occurred in Egypt about 4000 years ago. (From Walker's Mammals of the World, 6th ed, p801) Felis catus,Felis domesticus,Domestic Cats,Felis domestica,Felis sylvestris catus,Cat,Cat, Domestic,Cats, Domestic,Domestic Cat

Related Publications

R Nakajima, and Y Take, and R Moriya, and Y Saji, and T Yui, and Y Nagawa
January 1974, Xenobiotica; the fate of foreign compounds in biological systems,
R Nakajima, and Y Take, and R Moriya, and Y Saji, and T Yui, and Y Nagawa
July 1974, Xenobiotica; the fate of foreign compounds in biological systems,
R Nakajima, and Y Take, and R Moriya, and Y Saji, and T Yui, and Y Nagawa
January 1974, Xenobiotica; the fate of foreign compounds in biological systems,
R Nakajima, and Y Take, and R Moriya, and Y Saji, and T Yui, and Y Nagawa
April 1974, Xenobiotica; the fate of foreign compounds in biological systems,
R Nakajima, and Y Take, and R Moriya, and Y Saji, and T Yui, and Y Nagawa
January 1974, Xenobiotica; the fate of foreign compounds in biological systems,
R Nakajima, and Y Take, and R Moriya, and Y Saji, and T Yui, and Y Nagawa
April 1974, Xenobiotica; the fate of foreign compounds in biological systems,
R Nakajima, and Y Take, and R Moriya, and Y Saji, and T Yui, and Y Nagawa
June 1980, Journal of medicinal chemistry,
R Nakajima, and Y Take, and R Moriya, and Y Saji, and T Yui, and Y Nagawa
April 2013, Spectrochimica acta. Part A, Molecular and biomolecular spectroscopy,
R Nakajima, and Y Take, and R Moriya, and Y Saji, and T Yui, and Y Nagawa
January 1977, Drug metabolism and disposition: the biological fate of chemicals,
Copied contents to your clipboard!